Advanced Medical Training Fellowship – Oculoplastics and Oncology AND Vitreoretinal surgery

Advanced Medical Training Fellowship – Oculoplastics, Oncology and Vitreoretinal Surgery

Join to apply for the Advanced Medical Training Fellowship – Oculoplastics, Oncology and Vitreoretinal Surgery role at NHS Scotland.

NHS Greater Glasgow and Clyde is one of the largest healthcare systems in the UK, delivering acute hospital, primary, community and mental health care services to a population of over 1.15 million.

• Duration: 1 year, starting August 2026
• Location: NHS Greater Glasgow and Clyde, Scotland
• Type: Full‑time Advanced Medical Training Fellowship

• Inpatient and outpatient management of patients within the ophthalmology service.
• Assist at specialist clinic and theatre sessions.
• Participate in out‑of‑hours on‑call rota.
• Engage in specialist audit and research activities.

• Recently completed ophthalmic specialty training and awarded the CCT, or expected to be awarded before the post begins.
• Experience equivalent to CCT will be considered.
• Must hold FRCOphth or an equivalent qualification.
• GMC registration required and licence to practice in the UK.

• Oculoplastics and Oncology – Dr Vikas Chadha, Consultant Ophthalmologist, 0141 211 0124
• Oculoplastics and Oncology – Dr Paul Cauchi, Consultant Ophthalmologist, 0141 211 0124
• Vitreoretinal – Phone: 0141 211 1041 / 0141 211 0120
• Vitreoretinal – Dr S Saidkasimova, shohista.saidkasimovat
• Vitreoretinal – Dr A Cox, Alan.
  
  Cox3t
• Vitreoretinal – Dr G McGowan, Gerard.mcgowan2t
• Vitreoretinal – Dr D Yorston, David.
  
  Yorstont
• Vitreoretinal – Dr J Hind, jennifer.hind2t

NHS Greater Glasgow and Clyde- NHS Scotland encourages applications from all sections of the community, promoting a culture of inclusion. The organisation is a Forces‑Friendly Employer and supports applications from the Armed Forces Community.

Applicants should provide original and authentic responses. The use of artificial intelligence or automated tools to create or significantly modify responses is strongly discouraged. Non‑compliance may result in withdrawal from the application process.